News

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of ...
Smart glasses with augmented reality functions look more natural than VR goggles, but today they are heavily reliant on a ...
Giving a P2Y12 inhibitor anti-clotting drug to patients with coronary artery disease is associated with lower rates of cardiovascular death, heart ...
Rilzabrutinib is a promising treatment option for patients with chronic spontaneous urticaria who are refractory to antihistamines.
Ballycroy Women’s Group recently held a successful fundraising event in support of the Mayo Roscommon Hospice Foundation. Through the generous support of the local community and the efforts of the ...
As you gear up for summer travel, think about how to protect your information using a basic phone if you're crossing into the ...
Recently published comparative study evaluated the efficacy of different airway devices—endotracheal tube (ETT), supraglottic ...
The risk for COVID-19-related hospitalization was not significantly different between vaccinated older adults with vs without age-restrictive access to nirmatrelvir-ritonavir.
Adding simvastatin to escitalopram did not improve depressive symptoms in patients with major depression and obesity. Add-on ...
A study published in JAMA Network Open has found that exercising three days a week significantly improved sexual function, ...
During Q1, the Harbor Core Bond Fund returned 2.70%, slightly underperforming its benchmark, the Bloomberg US Aggregate Bond ...
A guideline-recommended 6-week regimen of corticosteroids for pneumonitis associated with immunotherapy significantly ...